Andrew A. Nierenberg, MD, explains how a learning health network helps clinicians measure outcomes and redesign bipolar disorder care together with patients.
News|Articles|March 26, 2024
Evidence-Based Novel Therapies for Bipolar Depression: Top 5 Takeaways
Author(s)Erin O'Brien
Expiring on May 20, 2024, this CME discusses how to apply several novel treatment approaches in the treatment of patients with bipolar depression. Here are 5 key takeaways.
Advertisement
Advertisement
Related to this article
Phase 3 psilocybin and LSD data plus new FDA guidance fuel a depression boom—yet clinics still wrestle with dosing time, cost, access.
Advertisement
Advertisement
Trending on Psychiatric Times
1
The New, Impending Adult ADHD Guidelines
2
What Makes Us Human? The Role of Psychiatry and the Future DSM
3
Reimbursement and Resources: Preparing Clinics for Psilocybin Therapy
4
Two New MDD Approvals: 5-HT1A Agonism and Adjunctive Atypical Antipsychotics
5